KUALA LUMPUR, July 31 (Bernama) -- Bursa Malaysia ended higher on Friday as investors continued to accumulate blue-chip stocks in line with stronger performances across most regional markets. At 5 pm, the FTSE Bursa Malaysia KLCI (FBM KLCI) rose 4.50 points to 1,724.90 from yesterday’s close of 1,720.40. The benchmark index opened 0.83 of a point higher at 1,721.23, and moved between 1,715.67 and 1,730.12 throughout the day. The broader market was positive with gainers outpacing losers 707 to 402, while 547 counters were unchanged, 1,085 untraded and 56 suspended. Turnover expanded to 3.03 billion units valued at RM3.56 billion from 2.49 billion units valued at RM2.25 billion on Thursday.
JD Health, China’s leading online healthcare platform and pharmacy operator, continues to deliver robust fundamentals with three-year net profit CAGR projected at 15% and stable net margins of 6%–7%. Backed by rising demand for digital healthcare, an aging population, and a growing focus on wellness and prevention, JD Health is positioning itself as a long-term structural growth story in the consumer healthcare space.
Technical Strength
The stock has rebounded above its 20-day EMA on stronger volume.
The MACD line is trading above its signal, confirming short-term momentum.
With support at HKD 41.80, a move toward HKD 44.60 is likely.
📊 Financial Highlights
| FY | Revenue (HKD m) | Net Profit (HKD m) |
|---|---|---|
| 2025F | 72,874 | 4,938 |
| 2026F | 82,269 | 5,506 |
| 2027F | 92,522 | 6,211 |
Why We Like JD Health
Leader in online pharmacy and integrated healthcare services.
Strong scalability with an expanding user base and product portfolio.
Resilient e-commerce distribution model in a fast-growing sector.
No dividend yield—earnings are reinvested into growth.
Conclusion:
With 19 Buy calls vs. just 1 Sell, JD Health is a consensus favorite among analysts. For investors seeking exposure to the convergence of tech and healthcare in China, JD Health offers a compelling entry point with solid earnings momentum, scalable operations, and positive technicals.
Comments
Post a Comment